In this competing renewal, we propose to build upon and extend our recent work on endogenous hormones and risk of breast cancer and also to evaluate several new breast cancer hypotheses. In addition, we propose to address a number of new hypotheses in relation to risk of ovarian cancer, a highly lethal cancer in women for which few prospective evaluations of biomarkers have been conducted. To accomplish these aims, we will conduct two nested case-control studies using already collected biologic samples from the Nurses' Health Study (for breast and ovarian cancers), and both the Women's Health Study and Nurses' Health Study II (for ovarian cancer only). Specifically, we will evaluate plasma estrogen metabolites, prolactin (using two blood samples collected 10 years apart), urinary melatonin, and urinary vs. plasma estrone sulfate, all in relation to breast cancer risk. Further, we will evaluate the independent contribution of endogenous sex steroids to the Gall and Rosner individual breast cancer risk prediction models. We also will evaluate plasma insulin like growth factors, androgens, vitamin D, and polymorphisms in both the progesterone receptor and vitamin D receptor in relation to ovarian cancer risk. Our proposed ovarian cancer aims, with 282 cases in plasma analyses and 521 cases in genetic analyses (all with 2 controls per case), will provide either the first or by far the most detailed prospective assessment of these potentially important risk factors. Finally, as a methodologic aim, we propose several pilot studies to evaluate the feasibility of using mass spectrometry technology (SELDI-TOF) in our cohorts to identify plasma protein profiles that predict subsequent cancer risk. Overall, the large size of these cohorts, their prospective design, high follow-up rates, detailed exposure data collected over many years, and the availability of archived plasma, DNA and urine specimens provides a unique opportunity to test a number of hypotheses of public health importance.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA049449-15
Application #
6782280
Study Section
Special Emphasis Panel (ZRG1-BMRD (02))
Program Officer
Patel, Appasaheb1 R
Project Start
1989-06-01
Project End
2009-03-31
Budget Start
2004-05-15
Budget End
2005-03-31
Support Year
15
Fiscal Year
2004
Total Cost
$1,243,784
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Barbhaiya, Medha; Tedeschi, Sara K; Lu, Bing et al. (2018) Cigarette smoking and the risk of systemic lupus erythematosus, overall and by anti-double stranded DNA antibody subtype, in the Nurses' Health Study cohorts. Ann Rheum Dis 77:196-202
Zong, Geng; Valvi, Damaskini; Coull, Brent et al. (2018) Persistent organic pollutants and risk of type 2 diabetes: A prospective investigation among middle-aged women in Nurses' Health Study II. Environ Int 114:334-342
Theofylaktopoulou, Despoina; Midttun, Øivind; Ueland, Per M et al. (2018) Impaired functional vitamin B6 status is associated with increased risk of lung cancer. Int J Cancer 142:2425-2434
Jung, Seungyoun; Allen, Naomi; Arslan, Alan A et al. (2018) Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts. Int J Cancer 142:262-270
Wong, Wing H; Tong, R Spencer; Young, Andrew L et al. (2018) Rare Event Detection Using Error-corrected DNA and RNA Sequencing. J Vis Exp :
Sun, Qi; Zong, Geng; Valvi, Damaskini et al. (2018) Plasma Concentrations of Perfluoroalkyl Substances and Risk of Type 2 Diabetes: A Prospective Investigation among U.S. Women. Environ Health Perspect 126:037001
Chang, Shun-Chiao; Crous-Bou, Marta; Prescott, Jennifer et al. (2018) Relation of long-term patterns in caregiving activity and depressive symptoms to telomere length in older women. Psychoneuroendocrinology 89:161-167
Ge, Wenzhen; Clendenen, Tess V; Afanasyeva, Yelena et al. (2018) Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts. Int J Cancer 142:2215-2226
Xu, Yinghui; Wang, Yanru; Liu, Hongliang et al. (2018) Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival. Mol Carcinog 57:22-31
Song, Mingyang; Zheng, Yan; Qi, Lu et al. (2018) Associations between genetic variants associated with body mass index and trajectories of body fatness across the life course: a longitudinal analysis. Int J Epidemiol 47:506-515

Showing the most recent 10 out of 526 publications